The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Femara 2.5 mg film-coated tablets

Novartis Ireland LimitedPA0896/012/001

Main Information

Trade NameFemara 2.5 mg film-coated tablets
Active SubstancesLetrozole
Dosage FormFilm-coated tablet
Licence HolderNovartis Ireland Limited
Licence NumberPA0896/012/001

Group Information

ATC CodeL02BG Aromatase inhibitors
L02BG04 letrozole


License statusAuthorised
Licence Issued10/01/1997
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0117-018-003
Interchangeable List DocumentPDF of Interchangeable List
« Back